UBS Asset Management

0 employees

UBS Asset Management delivers to the UK market the extensive capabilities of a truly global organisation.

Investor insights

Sectors invested in

Therapeutics5

Health Care5

Biotechnology5

Life Science2

Medical2

Pharmaceutical2

T cell biology2

Molecular biology2

Oncology2

Immunology2

Treg2

Cell Therapy2

Cancer therapy2

Online Retail1

Telecommunications1

E-Commerce Platforms1

Parking1

Food Delivery1

Last Mile Transportation1

Business Intelligence1

Funding rounds participated in

$65M sweet spot round size

Most of their 8 investments are in rounds between $45M and $125M

Basic info

Industry

financial services

Sectors

High Alpha

Asset Management

Hedge Funds

Passive

Sustainability Investing

Investment

Finance

Alternatives

Fund Advisory

Fixed Income

Sustainable Investing

Fund Management Services

Financial Services

Global Real Estate

ETF

Equities

Risk Management

Date founded

1895

Investments made

Branded Online Ecommerce raised $60M on August 30, 2022

Investors: Tenor and UBS Asset Management

REEF raised $700M on November 3, 2020

Investors: Oaktree Capital Management, L.P., Target Global, SoftBank Group International and UBS Asset Management

Altitude Infrastructure raised $590M on September 17, 2020

Investors: UBS Asset Management

Harpoon Therapeutics raised $70M on November 12, 2018

Investors: MPM Capital, NS Investment, Ridgeback Capital Management LLC, Lilly Asia Ventures, Arix Bioscience plc, OrbiMed Advisors, New Leaf Venture Partners and UBS Asset Management

TCR² Therapeutics Inc. raised $125M on March 21, 2018

Investors: Syno Capital, Redmile Group, Hillhouse Capital Management, Mirae Asset MAPS Global Investments Co., Ltd, MPM Capital, Haitong International Securities Group Limited, Sirona Capital and UBS Asset Management

Harpoon Therapeutics raised $45M on May 25, 2017

Investors: MPM Capital, New Leaf Venture Partners, Arix Bioscience plc and UBS Asset Management

TCR² Therapeutics Inc. raised $45M on December 8, 2016

Investors: MPM Capital and UBS Asset Management

Harpoon Therapeutics raised $15M on April 1, 2016